Proceedings of the National Academy of Sciences · 2015 · 101 citations · 25 references
MedicineMolecular BiologyOncologyGene ExpressionMolecular OncologyTumor ProgressionCancer BiomarkersCancer Cell SignalingCancer CytogeneticsCancer GenomicsMolecular Tumor ProfilingOncogenic Signaling PathwaysCellular OncogenesNon-small Cell Lung Cancer TherapyNoncoding Rna-mediated Gene RegulationPredictive Biomarker AssessmentPredictive Biomarker DiscoveryRna Binding Protein RegulationRna-binding Protein InteractionsRna-protein Binding
Aberrant expression of RNA-binding proteins has profound implications for cellular physiology and the pathogenesis of human diseases such as cancer. We previously identified the Fragile X-Related 1 gene (FXR1) as one amplified candidate driver gene at 3q26-29 in lung squamous cell carcinoma (SCC). FXR1 is an autosomal paralog of Fragile X mental retardation 1 and has not been directly linked to human cancers. Here we demonstrate that FXR1 is a key regulator of tumor progression and its overexpression is critical for nonsmall cell lung cancer (NSCLC) cell growth in vitro and in vivo. We identified the mechanisms by which FXR1 executes its regulatory function by forming a novel complex with two other oncogenes, protein kinase C, iota and epithelial cell transforming 2, located in the same amplicon via distinct binding mechanisms. FXR1 expression is a candidate biomarker predictive of poor survival in multiple solid tumors including NSCLCs. Because FXR1 is overexpressed and associated with poor clinical outcomes in multiple cancers, these results have implications for other solid malignancies.
25
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Jordi Barretina, Giordano Caponigro, Nicolas Stransky et al. · Nature · 2012 · 8.5K citations
Medicine, Oncology, Pharmacology +15
Pan-cancer patterns of somatic copy number alteration
Travis Zack, Steven E. Schumacher, Scott L. Carter et al. · Nature Genetics · 2013 · 2K citations · Full text
Life Sciences, Genetics, Oncology +17
SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas
Adam J. Bass, Hideo Watanabe, Craig H. Mermel et al. · Nature Genetics · 2009 · 952 citations · Full text
FMRP targets distinct mRNA sequence elements to regulate protein expression
Manuel Ascano, Neelanjan Mukherjee, Pradeep Bandaru et al. · Nature · 2012 · 729 citations
RNA-binding proteins in human genetic disease
Kiven Erique Lukong, Kai-Wei Chang, Stéphane Richard · Trends in Genetics · 2008 · 691 citations